83 related articles for article (PubMed ID: 6133719)
1. The bioavailability and disposition of tiodazosin levulinate in beagle dogs with a comparison to prazosin hydrochloride.
Baughman RA; Mico BA; Benet LZ
Drug Metab Dispos; 1983; 11(2):143-6. PubMed ID: 6133719
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent bioavailability of prazosin in beagle dogs.
Baughman RA; Sorgel F; Mico BA; Benet LZ
J Cardiovasc Pharmacol; 1983; 5(4):613-7. PubMed ID: 6193359
[TBL] [Abstract][Full Text] [Related]
3. Prazosin first-pass metabolism and hepatic extraction in the dog.
Rubin P; Yee YG; Anderson M; Blaschke T
J Cardiovasc Pharmacol; 1979; 1(6):641-7. PubMed ID: 94630
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of prazosin.
Jaillon P
Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
[TBL] [Abstract][Full Text] [Related]
5. The metabolic fate of prazosin.
Taylor JA; Twomey TM; von Wittenau MS
Xenobiotica; 1977 Jun; 7(6):357-64. PubMed ID: 610052
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs.
Flory AB; Rassnick KM; Balkman CE; Kiselow MA; Autio K; Beaulieu BB; Lewis LD
Am J Vet Res; 2008 Oct; 69(10):1316-22. PubMed ID: 18828689
[TBL] [Abstract][Full Text] [Related]
8. Prazosin, pharmacokinetics and concentration effect.
Bateman DN; Hobbs DC; Twomey TM; Stevens EA; Rawlins MD
Eur J Clin Pharmacol; 1979 Sep; 16(3):177-81. PubMed ID: 499317
[TBL] [Abstract][Full Text] [Related]
9. In vitro comparison of the pre- and postsynaptic alpha adrenergic receptor blocking properties of prazosin and tiodazosin (BL5111).
Cohen ML; Wiley KS; Landry AS
Clin Exp Hypertens (1978); 1980; 2(6):1067-82. PubMed ID: 6108842
[TBL] [Abstract][Full Text] [Related]
10. Prazosin disposition in young and elderly subjects.
Rubin PC; Scott PJ; Reid JL
Br J Clin Pharmacol; 1981 Sep; 12(3):401-4. PubMed ID: 7295470
[TBL] [Abstract][Full Text] [Related]
11. [Biological availability and pharmacological effects of Prazosin VUFB in dogs].
Sedlmayer P; Sispera L; Rejholec V; Chaura Z
Cesk Farm; 1984 Jul; 33(6):235-7. PubMed ID: 6498957
[No Abstract] [Full Text] [Related]
12. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
[TBL] [Abstract][Full Text] [Related]
13. Prazosin kinetics in essential hypertension.
Chau NP; Flouvat BL; Le Roux E; Safar ME
Clin Pharmacol Ther; 1980 Jul; 28(1):6-11. PubMed ID: 7389255
[TBL] [Abstract][Full Text] [Related]
14. Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: influence of lipid co-administration.
Lallemand E; Lespine A; Alvinerie M; Bousquet-Melou A; Toutain PL
J Vet Pharmacol Ther; 2007 Oct; 30(5):375-80. PubMed ID: 17803727
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
Dalton JT; Meyer MC; Golub AL
Drug Metab Dispos; 1999 Apr; 27(4):432-5. PubMed ID: 10232930
[TBL] [Abstract][Full Text] [Related]
16. Disposition of abouthiouzine: a novel antihyperthyroid drug.
Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
[TBL] [Abstract][Full Text] [Related]
17. Prazosin kinetics in hypertension.
Grahnén A; Seideman P; Lindström B; Haglund K; von Bahr C
Clin Pharmacol Ther; 1981 Oct; 30(4):439-46. PubMed ID: 7285477
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
[TBL] [Abstract][Full Text] [Related]
19. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.
Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
